11-26-2018 01:19 PM CET - Health & Medicine
Print

Global Cardiac Marker Testing Market strategically important analysis with top players like Medtronic, BD, Merck Group, LivaNova, Roche, Randox, Beckman Coulter, Quidel, Getinge, Siemens, Danaher Corporation, bioMérieux, Abcam, Inova Diagnostics

Press release from: Data Bridge Market Research
Cardiac Marker Testing share and trends
Cardiac Marker Testing share and trends


Cardiac Marker Testing market report delivers a detailed study with present and upcoming Opportunities to clarify the future investment and business plans of the market. The report contains complete analysis regarding type and applications, featuring the key business resources and provides an in-depth survey of top key vendors. This analysis gives an examination of various segments that are relied upon to witness the quickest development amid the estimate forecast frame. The Cardiac Marker Testing market study also analyzes the market status, share, growth rate, future trends, drivers, opportunities, challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The Global Cardiac Marker Testing Market is expected to reach USD 4.77 billion by 2025, from USD 2.48 billion in 2017 growing at a CAGR of 8.5% during the forecast period of 2018 to 2025.

Read Comprehensive Overview | Instantly Available At databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Major Companies Covered

Siemens, Danaher Corporation, bioMérieux, Ortho Clinical Diagnostics, Randox, Beckman Coulter, Quidel, Getinge, Medtronic, BD, Merck Group, LivaNova, Roche, Abcam, Inova Diagnostics, A Werfen Company, Abbott Diagnostics Business LSI, Bio-Rad Laboratories, LifeSign LLC, ZEUS Scientific ,ERBA Diagnostics, Inc., Medience Corporation, Guangzhou Wondfo Biotech Co., Ltd., MBL International Corporation, Merck KGaA, Darmstadt, Germany, HOB Biotech Group, Suzhou Lixinpharm Co.,Ltd, Human Diagnostics and others.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: PIPELINE ANALYSIS

• Pipeline analysis

PART 06: MARKET SIZING

• Market definition
• Market sizing
• Market size and forecast

PART 07: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 08: MARKET SEGMENTATION

• Segmentation
• Comparison
• Market opportunity

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

• Geographical segmentation
• Regional comparison
• North America
• South America
• Europe
• MEA
• APAC
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 15: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors

PART 16: APPENDIX

• List of abbreviations

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Toc Is Available | Request At databridgemarketresearch.com/toc/?dbmr=global-cardiac-mar...

Market Drivers and Restraints

• Rapidly growing human population and their eagerness towards healthcare expenditure.

• The increasing cases of cardiovascular disease among the population.

• Increase in funding from private and government for R&D.

• Increasing Asia Pacific economy has quite a lot of opportunities.

• Stringent government norms and regulations for the use and approval of medical devices.

• Technical issues related to storage and collection of samples.

Key Developments

• In September 2018, LivaNova propelled an International Pivotal Study assessing utilization of autonomic control treatment for heart disappointment, demonstrating the company’s essence and commitment towards changing lives through the advancement and presentation of innovations, tending to the neglected needs in the worldwide restorative network.

• The investigation of cardiovascular biomarkers has turned into the principal line of indicative devices for AMI, empowering doctors in fast analysis and quick making arrangements for treatment, prompting diminished the death rate.

• Research at the Baylor College of Medicine revealed that, using diagnostic nanochips and a swab of the cheek, cardiac biomarker readings from saliva along with the ECG readings can determine within minutes if someone is likely to have had a heart attack.

Why Data Bridge Market Research?

• Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report.

• Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report.

• Inimitable Expertise: Analysts will provide deep insights about the reports

• Assured Quality: We focus on the quality and accuracy of the report

• Technically acclaimed Analysts with complete industry know how Robust research methodology followed by our publishers to arrive at market estimates, Focus on technology trends, Extensive repository of market research reports to meet our client’s needs.

• Based on extensive research, we provide clear view of real market scenario and help clients with making informed business decisions

GAIN EASY INQUIRY OF THIS REPORT, ALONG WITH ON-DEMAND SERVICES

Get Expert’s Insights at databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Market Segmentation

Based on type,

• Troponin I and T,
• CK-MB,
• Myoglobin,
• Brain natriuretic peptide,
• C – Reactive protein, other biomarkers

The other biomarker segment is further segmented into

• Galectin-3,
• H-FABP,
• Myeloperoxidase,
• Ischemia-modified albumin, and
• Homocysteine

Based on product, the market is segmented into

• Instruments,
• chemiluminescence,
• Immunofluorescence,
• ELISA,
• immunochromatography and
• Reagents & kits

Based on disease, the market is segmented into

• Myocardial infarction and
• Congestive heart failure

Based on type of testing, the market is segmented into

• Laboratory testing and
• Point-of-care testing

By Geography

• Asia Pacific (China, South Korea, Japan, India, Australia, Singapore, Thailand, Indonesia, Malaysia, Philippines, Rest of Asia-Pacific).

• North America (US, Canada, Mexico).

• Europe (Russia, Turkey, Belgium, Netherlands, Switzerland, Spain, France, Germany, Italy, UK, Rest of Europe.

• South America (Brazil, Argentina, Rest of South America).

• Middle East and Africa (South Africa, Egypt, Saudi Arabia, United Arab Emirates, Israel, Rest of Middle East and Africa).

Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team (sopan.gedam@databridgemarketresearch.com), who will ensure that you get a report that suits your needs.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1399014 • Views: 121
More releasesMore releases

You can edit or delete your press release here: